Discover 440 paid clinical trials in Rochester, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Rochester has a wide variety of active clinical trials, focusing on conditions such as kidney disease, cancer, and cardiovascular disorders. Participants in these studies have the opportunity to explore emerging treatments in the city’s leading research institutions, both as healthy volunteers in paid trials and as individuals looking for studies targeting specific health conditions.
Filter
2
Filter results
Results: 440
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: Rochester NY, New York NY, New Haven CT, Detroit MI,
Sponsor: Panbela Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05254171
Phase 2, Phase 3, Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Get alerts for new trials in your area by subscribing now
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
for
Head and Neck Cancer
Location: Rochester NY
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT04805528
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
for
Carotid Artery Diseases
Location: Rochester NY, New York NY, Cincinnati OH,
Sponsor: InspireMD
Sex: All
Age: 18 - 70+
Code: NCT06653387
Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis
Location: Rochester NY, New York NY, Philadelphia PA,
Sponsor: Cumberland Pharmaceuticals
Sex: All
Age: 40+
Code: NCT05571059
Phase 2, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,